
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Wall Street
Price Targets
Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd
According to Wall Street analysts, the average 1-year price target for
Shandong Weigao Group Medical Polymer Co Ltd
is 6.54 HKD
with a low forecast of 5.25 HKD and a high forecast of 7.77 HKD.
Revenue
Forecast
Revenue Estimate
Shandong Weigao Group Medical Polymer Co Ltd
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
7%.
Operating Income
Forecast
Operating Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's operating income is
9%.
The projected
CAGR
for the next 3 years is
11%.
Net Income
Forecast
Net Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's net income is
8%.
The projected
CAGR
for the next 3 years is
10%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shandong Weigao Group Medical Polymer Co Ltd's stock price target?
Price Target
6.54
HKD
According to Wall Street analysts, the average 1-year price target for
Shandong Weigao Group Medical Polymer Co Ltd
is 6.54 HKD
with a low forecast of 5.25 HKD and a high forecast of 7.77 HKD.
What is Shandong Weigao Group Medical Polymer Co Ltd's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
7%.
What is Shandong Weigao Group Medical Polymer Co Ltd's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's operating income is
9%.
The projected
CAGR
for the next 3 years is
11%.
What is Shandong Weigao Group Medical Polymer Co Ltd's Net Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Shandong Weigao Group Medical Polymer Co Ltd's net income is
8%.
The projected
CAGR
for the next 3 years is
10%.